World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS MANAGEMENT- A CRITICAL REVIEW

Dr. Nancy Panjeta*, Dr. Rajnikant Rohilla and Dr. Charu Sharma

ABSTRACT

Public health is facing an increasing problem due to the harmful impacts of non-alcoholic fatty liver disease (NAFLD), as diabetes and obesity are becoming more common place globally. In the Western world, non-alcoholic fatty liver disease (NAFLD) is most prevalent. Metabolic diseases such as central obesity, dyslipidemia, hyperglycemia, and chronic abnormalities in liver function tests are intimately linked to non-alcoholic fatty liver disease (NAFLD). Generally, NAFLD is a term used to describe a wide range of liver disease, including fibrosis, inflammatory processes, and hepatocellular injury. Ayurveda being the oldest healing science has vividly described liver diseases in the context of „Yakrit roga’ in classical texts. NAFLD can be interpreted as a „Santarpanjanya vikara’ with kapha medho dushti and its sthanasamsraya in Yakrit, which is said to be Raktavaha srotomoola and Pittasthana.[1] There is no description of Yakrit vikara as a separate chapter in Ayurvedic classics, only Bhavprakash mentioned it as a separate chapter. Description of Yakritdalyodara is found while describing Pleehodara in the Brihat trayees.[1] The few suggested evidences for practice and production more information to help stop the progression of fatty liver diseases and to prevent them.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR